Revised. Amendments from Version 1
==================================

Raw images of all western blots were added in a PDF format as well as TIFFs, to enable all readers to view the raw data files. The data itself is unchanged.

Introduction
============

Malate dehydrogenases (Mdhs) catalyse the interconversion of malate and oxaloacetate using NAD ^+^ or NADH ^[@ref-1]^. In the yeast *Saccharomyces cerevisiae* there are three known isozymes: Mdh1 is located in mitochondria, Mdh2 is mostly cytosolic, and Mdh3 is localized to peroxisomes. The residues of the three isozymes are between 43--50% identical ^[@ref-2]^. It is thus very important for purposes of isolation and identification to utilize specific antibodies that will recognize only one specific isozyme. Using three Mdh2 peptides, which were specifically designed to unique regions in the Mdh2 protein, GenScript USA produced three different antibodies that should have high specificity for *S. cerevisiae* Mdh2 relative to Mdh1 and Mdh3. We then tested all three antibodies by western blotting and found one with specific binding. Due to its specificity, this antibody has the potential to also work in other experimental assays such as immunoprecipitation, immunohistochemistry and ELISA (Enzyme-Linked Immunosorbent Assay).

Methods
=======

Antibody details
----------------

Three antibodies for *S. cerevisae* Mdh2 were custom produced for us by GenScript USA : 1. Purified antibody, Anti-peptide \#1, item number: U1684BK300_2, LOT number: A416120074, catalogue number: SC1195. 2. Purified antibody, Anti-peptide \#2, item number: U1684BK300_5, LOT number: A416120094, catalogue number: SC1195. 3. Purified antibody, Anti-peptide \#3, item number: U1684BK300_8, LOT number: A416120072, catalogue number: SC1195.

All three antibodies were raised in New Zealand Rabbit and are polyclonal. The immunogen for all three antibodies is conjugated KLH Peptide. To find specific Mdh2 peptides, the three *S. cerevisiae* malate dehydrogenases (Mdh1, Mdh2 and Mdh3) were aligned and analysed by GenScript, using their [Antigen Design Tool](https://www.genscript.com/antigen-design.html). From this analysis, three peptides (corresponding to the three antibodies) were selected: \#1: CHPQSRNSGIERRIM; \#2: CINIESGLTPRVNSM; \#3: MPHSVTPSIEQDSLC. The cysteines in the N' terminus (peptides number 1 and 2) or C' terminus (peptide number 3) were added for KLH conjugation.

Yeast strains and strain construction
-------------------------------------

Yeast strains are all based on the BY4741 laboratory strain ^[@ref-3]^. Manipulations were performed using a standard PEG/LiAC transformation protocol ^[@ref-4]^. The GFP-Mdh1, GFP-Mdh2, GFP-Mdh3 and OE-mCherry-Mdh3 strains were picked from the SWAT N' GFP or N' mCherry yeast libraries that were recently prepared in our lab ^[@ref-5]^. All Strains with a fluorescent tag, including the strains that were picked from the SWAT libraries were verified using PCR (one primer from within the endogenous Open Reading Frame (ORF) and one from within the tag sequence) as well as by fluorescent microscopy. Primers for creating strains with deletions or C' tagging of genes (Δ *mdh1*, Δ *mdh2*, Δ *mdh3* and Mdh2-mCherry) were designed using the [Primers-4-Yeast web tool](http://www.weizmann.ac.il/Primers-4-Yeast/) ^[@ref-6]^. All deletions were verified using primers from within the endogenous ORF. All primers are summarized in [Table 1](#T1){ref-type="table"}.

###### A list of primers used in this study.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene         Primer Name             Sequence                                                       Description
  ------------ ----------------------- -------------------------------------------------------------- -----------------------------------------------------
  *MDH1*       *MDH1* KO pFA6 F        AAAAAAAACAAAAGGAAAAGGAAGGATACCATATACAATGCGGATCCCCGGGTTAATTAA   Primer for KO of gene using pFA6 plasmids.

  *MDH1*       *MDH1* KO pFA6 R        TTCCCTATTTTTCACTCTATTTCTGATCTTGAACAATCTAGAATTCGAGCTCGTTTAAAC   Primer for KO of gene using pFA6 plasmids.

  *MDH1*       *MDH1* N\' tag CHK R    TGGAACGGTAGAATTGACTG                                           Primer for checking N\' tagging of the gene.

  *MDH1*       *MDH1* WT CHK F         TCCAACCCAGTCAATTCTAC                                           Primer for testing the presence of the gene.

  *MDH1*       *MDH1* WT CHK R         GTTAGCGAATTTAGCACCAG                                           Primer for testing the presence of the gene.

  *MDH2*       *MDH2* KO pFA6 F        CAAAAGTTCAATACAATATCATAAAAGTTATAGTAACATGCGGATCCCCGGGTTAATTAA   Primer for KO of gene using pFA6 plasmids.

  *MDH2*       *MDH2* KO pFA6 R        CAATTTGCTGCATTCTTATGCTTCGGTCCGATGCTCATTAGAATTCGAGCTCGTTTAAAC   Primer for KO of gene using pFA6 plasmids.

  *MDH2*       *MDH2* N\' tag CHK R    TGGAAATGACAAGAACGAAG                                           Primer for checking N\' tagging of the gene.

  *MDH2*       *MDH2* WT CHK F         AACTGTTTGCATAACGCTTC                                           Primer for testing the presence of the gene.

  *MDH2*       *MDH2* WT CHK R         CATGGAGTTAACACGAGGAG                                           Primer for testing the presence of the gene.

  *MDH2*       *MDH2* C\' tag CHK F    ATTCCGTTGTTTTCACAGTC                                           Primer for checking C\' tagging of the gene.

  *MDH2*       *MDH2* C\' tag pFA6 F   TAAGGGCTTGGAATTCGTTGCATCGAGATCTGCATCATCTCGGATCCCCGGGTTAATTAA   Primer for C\' tagging of gene using pFA6 plasmids.

  *MDH2*       *MDH2* C\' tag pFA6 R   CAATTTGCTGCATTCTTATGCTTCGGTCCGATGCTCATTAGAATTCGAGCTCGTTTAAAC   Primer for C\' tagging of gene using pFA6 plasmids.

  *MDH3*       *MDH3* KO pFA6 F        TGCAAAAGAAAATAAAAAGAGACAAACAATCATAAACATGCGGATCCCCGGGTTAATTAA   Primer for KO of gene using pFA6 plasmids.

  *MDH3*       *MDH3* KO pFA6 R        AGTATAGAGTTAAGAAAAATATAAAAATTGAAGTAGCTCAGAATTCGAGCTCGTTTAAAC   Primer for KO of gene using pFA6 plasmids.

  *MDH3*       *MDH3* N\' tag CHK R    TTCTTCAAAGTTTCCACAGC                                           Primer for checking N\' tagging of the gene.

  *MDH3*       *MDH3* WT CHK F         ATTCAGGGGAAACCATTATC                                           Primer for testing the presence of the gene.

  *MDH3*       *MDH3* WT CHK R         TCGATGGATACTACGCTACC                                           Primer for testing the presence of the gene.

  *MDH1/2/3*   N \'tag CHK F           CGACAGAGAATTCATCGATG                                           Primer for checking N\' tagging. Using pym plasmid

  *MDH1/2/3*   F2-Rev-Com              TTAATTAACCCGGGGATCCG                                           Reverse complementary to the F1/F2 primer of the\
                                                                                                      Longtine\'s pFA6a plasmids.
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

Western blot analysis
---------------------

Yeast proteins were extracted by the NaOH protocol as previously described ^[@ref-7]^ and resolved on polyacrylamide gels with the following modifications: 1.Liquid cultures were grown over night at 30°C in glucose containing media, and then were diluted and incubated for an additional 4--6 hours to get to mid-log phase. Cells that were grown in a different carbon source than glucose were grown in synthetic media with 0.1% glucose (6.7 g/l yeast nitrogen base and 0.1% glucose) for the overnight incubation, then diluted in synthetic media containing galactose (6.7 g/l yeast nitrogen base and 2% galactose) or oleic acid (6.7 g/l yeast nitrogen base, 0.2% oleic acid and 0.1% Tween-80) and incubated for an additional 4--6 hours. Cells that were grown in glucose were grown in yeast extract peptone dextrose (YPD) rich medium (1% Yeast Extract, 2% peptone, 2% glucose) for the whole process.2.The extractions were incubated for 10 minutes at 70°C and 15 µl supernatant was loaded per lane of the gel.

The gels were transferred to nitrocellulose membrane blots, blocked for 1 hour in SEA block diluted in TBS-T (1:5) at room temperature (RT), and probed with primary rabbit/mouse antibodies against Mdh2, Histone H3, Actin and mCherry ( [Table 2](#T2){ref-type="table"}) for 1 hour at RT. Final concentrations of the primary antibodies were: 1 µg/ml for anti-Mdh2 peptides \#1 and \#3, 0.5 µg/ml for anti-Mdh2 peptide \#2, anti-mCherry and anti-Actin and 0.2 µg/ml for anti-Histone H3. The membranes were washed 3 times without incubation in TBS-T, followed by 3x3 minute washes in TBS-T. The membranes were then probed with a secondary goat anti-rabbit/mouse antibody conjugated to IRDye800 or to IRDye680 ( [Table 2](#T2){ref-type="table"}) for 30 minutes at RT and washed as before. Final concentrations of the secondary antibodies were 0.1 µg/ml for IRDye 800CW Goat anti-Rabbit IgG and IRDye 680RD Goat anti-mouse IgG, and 0.2 µg/ml for Goat anti-mouse HRP conjugated. Membranes were scanned for infrared signal using the Odyssey Imaging System (Li-Cor). For detecting the anti-Actin primary antibody ( [Table 2](#T2){ref-type="table"}), a goat anti-mouse HRP conjugated secondary antibody ( [Table 2](#T2){ref-type="table"}) was used. The membrane was then washed with ECL reagents and scanned using imageQuant LAS 4000 system (GE Healthcare). Images were transferred to ImageJ 1.51s for slight adjustments of contrast and brightness. For further information about the western blot reagents see [Table 3](#T3){ref-type="table"}.

###### Primary and secondary antibodies.

  ------------------------------------------------------------------------------
  Antibody                             Manufacturer   Catalogue\   RRID
                                                      Number       
  ------------------------------------ -------------- ------------ -------------
  Rabbit anti-Mdh2 peptide \#1 (Ab1)   GenScript      SC1195       

  Rabbit anti-Mdh2 peptide \#2 (Ab2)   GenScript      SC1195       

  Rabbit anti-Mdh2 peptide \#3 (Ab3)   GenScript      SC1195       

  Mouse anti-mCherry                   Abcam          ab125096     AB_11133266

  Rabbit anti-Histone H3               Abcam          ab1791       AB_302613

  Mouse anti-Actin                     Abcam          ab8224       AB_449644

  IRDye 800CW Goat anti-Rabbit IgG     LI-COR, Inc    926-32211    AB_621843

  IRDye 680RD Goat anti-mouse IgG      LI-COR, Inc    926-68070    AB_10956588

  Goat anti-mouse HRP conjugated       Abcam          ab6789       AB_955439
  ------------------------------------------------------------------------------

###### Details of reagents for Western Blot.

  ---------------------------------------------------------------------------------------------------------------------
  Process                    Reagent                             Manufacturer        Catalogue Number   Concentration
  -------------------------- ----------------------------------- ------------------- ------------------ ---------------
  Protein extraction         Sodium hydroxide (NaOH)             Merck\              1064981000         0.2 M
                                                                 Chemicals                              

  5 X SDS sample buffer      β-mercapto-ethanol                  Sigma               02390-25ML         5%

  Bromophenol Blue           Amresco                             0449-50G            0.5%               

  Tris pH 6.8                MP Biomedicals                      819620              0.312 M            

  Glycerol                   J.T.Baker                           2136-01             25%                

  SDS                        Sigma                               L4509-500G          10%                

  Mdh2 Antibodies Diluent    BSA (in wash buffer)                MP Biomedicals      160069             1%

  Other antibodies Diluent   Skim milk powder (in wash buffer)   Tnuva-423           48703              5%

  10 X TBS-T Wash buffer     Tris 1 M pH 7.9                     MP Biomedicals      819620             10%

  Tween 20                   Sigma                               P1379-500ML         0.5%               

  0.5 M EDTA pH 8.0          J.T.BAKER                           8993-01             0.5%               

  NaCl                       J.T.BAKER                           0277                1.5 M              

  Blocking                   SEA block (in wash buffer)          Thermo scientific   37527              20%

  Chemiluminescence          Amersham ECL western blot\          GE Healthcare       RPN2106            Proprietary
                             reagents                                                                   
  ---------------------------------------------------------------------------------------------------------------------

Controls
--------

Several controls were used in this study. Loading controls for the total amount of protein were performed using anti-Histone H3 or anti-Actin antibodies. A Δ *mdh2* strain, alongside Δ *mdh1* and Δ *mdh3* strains, were used to verify the specificity of the Mdh2 antibodies. An anti-mCherry antibody was used as a control for the bands detected in Mdh2-mCherry or Tef2-mCherry-Mdh3 (over expression) compared to the bands detected by the anti-Mdh2 antibodies. An anti-GFP antibody was used as a control for the bands detected in GFP-Mdh1, GFP-Mdh2 and GFP-Mdh3 with anti Mdh2 antibody peptide \#3.

Results
=======

The three GenScript antibodies detect Mdh2 from cells grown on oleic acid
-------------------------------------------------------------------------

For first examination of the three antibodies, we grew control cells in three different carbon sources: glucose, galactose and oleic acid. Since transcription of *S. cerevisiae* Mdh2 is repressed by glucose ^[@ref-8]^, we hypothesized that the antibodies will not detect Mdh2 in extracts of cells grown in glucose, but will detect it in the galactose and oleic acid samples. We then performed protein extraction using the NaOH approach, and examined the three GenScript anti-Mdh2 antibodies.

Indeed, all three antibodies could not detect a specific band at the correct size of Mdh2 (41 KDa) in protein extractions from cells grown in glucose ( [Figure 1](#f1){ref-type="fig"}, Glu). Although the general protein levels of the control strain grown in oleic acid were much lower than from the levels of controls grown in glucose, a prominent band at the correct size for Mdh2 was detected by all three antibodies. In galactose there was no prominent band at the correct size, although this could be due to the general low levels of protein in this condition, as can be seen by the Histone H3 loading control. Endogenous Mdh2 was also recognized in protein extractions from cells grown on other carbon sources such as EtOH (not shown). This suggests that the upregulation of Mdh2 in cells grown in oleic acid is due to the removal of the glucose repression and not because of an oleic acid-specific up-regulation.

![Three new antibodies recognize Mdh2 in cells grown in oleic acid.\
Western blot analysis was performed on protein extracts of control cells (BY4741) grown in glucose (Glu), oleic acid (Ole) or galactose (Gal) using antibodies 1--3 (Ab1, Ab2, Ab3). Native Mdh2 (41 KDa) is detected by all three anti-Mdh2 antibodies in protein extractions from cells grown in oleic acid as indicated by yellow arrows. Histone H3 was used as a loading control. In total we detected seven times a band at the size of Mdh2 when cells were grown on Oleate: One time using antibody1, three times using antibody 2 and three times using antibody 3.](f1000research-7-17154-g0000){#f1}

Antibody 3 has high specificity for Mdh2
----------------------------------------

After the first comparison, we focused on antibodies 2 and 3 as they displayed the lowest background signal. We verified the affinity and specificity of the antibodies using several strains, in addition to the control strain: Δ *mdh1,* Δ *mdh2,* Δ *mdh3,* as well as strains that had a mCherry tag fused to either Mdh2 or Mdh3 or GFP tag fused to Mdh1, Mdh2 or Mdh3. Both antibody 2 and antibody 3 detected endogenous Mdh2 in wild type cells and in Δ *mdh3* cells grown in oleic acid ( [Figure 2](#f2){ref-type="fig"} and [Figure 3](#f3){ref-type="fig"}), but were specific to Mdh2 as they did not cross react in the Δ *mdh2* strain. Another way to demonstrate specificity is to tag Mdh2 with mCherry, thus shifting only this specific isoform in size. Indeed, under these conditions both antibodies 2 and 3 detected a higher protein form only (Mdh2 tagged with mCherry = ^∼^70 kDa), though with lower affinity. Reciprocally, neither antibody detected over expressed mCherry-Mdh3 (expressed under a Tef2 promotor), although it was highly expressed as could be verified by an anti-mCherry antibody. In addition, antibody 3 detected endogenous Mdh2 in Δ *mdh1* cells grown in oleic acid, as well as a bigger band size only in GFP-Mdh2 tagged cells (Mdh2 tagged with GFP = ^∼^68 kDa) ( [Figure 4](#f4){ref-type="fig"}). Although both antibodies fit the requirement of specific identification of the yeast Mdh2, we have decided to use antibody 3, as it has a better specificity as seen from the lower background signal ( [Figure 3](#f3){ref-type="fig"}).

![Antibody 2 displays isoform specificity.\
Western blot analysis was performed on protein extractions from different strains grown on oleic acid (Ole) or in glucose (only for OE-mCherry-Mdh3) using antibody 2 and anti-mCherry antibody. Antibody 2 recognizes the native Mdh2 in control cells and in Δ *mdh3* cells grown in oleic acid, but does not recognize it in Δ *mdh2* strain (second lane). The antibody also recognizes Mdh2 tagged with mCherry ( ^∼^70 kDa), but not the over-expressed and mCherry tagged Mdh3. The last one can be recognized in the control with the anti-mCherry. Histone H3 was used as a loading control. Yellow arrows indicate bands corresponding to Mdh2. (OE = over expression). We saw that antibody 2 specifically recognized Mdh2 and not Mdh3 in three experiments.](f1000research-7-17154-g0001){#f2}

![Antibody 3 has the best specificity to Mdh2.\
Western blot analysis was done on protein extractions from different strains grown on oleic acid (Ole) or glucose (Glu) (OE-mCherry-Mdh3 was grown in glucose) using antibody 3 and anti-mCherry. Similarly to antibody 2, antibody 3 does not recognize Mdh2 in Δ *mdh2* strain or in cells grown on glucose. This antibody has a good specificity to Mdh2, as seen by the low background signal. Actin was used as a loading control. Yellow arrows indicate bands corresponding to Mdh2. (OE = over expression). We saw that antibody 3 specifically recognizes Mdh2 in three experiments.](f1000research-7-17154-g0002){#f3}

![Antibody 3 recognizes Mdh2 in Δ *mdh1* and Δ *mdh3* cells extractions.\
Western blot analysis was done on protein extractions from different strains grown on oleic acid (Ole) using antibody 3 and an anti-GFP antibody. As shown in [Figure 3](#f3){ref-type="fig"}, this antibody does not recognize Mdh2 in Δ *mdh2* strain or in cells grown on glucose but does recognize Mdh2 in Δ *mdh3* cells grown on oleic acid. Here we show that antibody 3 also recognizes Mdh2 in Δ *mdh1* cells grown on oleic acid. Actin was used as a loading control. Yellow arrows indicate bands corresponding to Mdh2. We saw that antibody 3 specifically recognizes Mdh2 and not Mdh3 in two experiments and that antibody 3 does not recognize Mdh1 in one experiment.](f1000research-7-17154-g0003){#f4}
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Conclusion
==========

Three antibodies against endogenous *S. cerevisiae* Mdh2 were prepared by GenScript, using specific peptides of Mdh2 as the immunogens. The antibodies were checked by western blot and were shown to have the ability to detect endogenous Mdh2, when cells are grown under conditions in which Mdh2 is expressed. Although two of the three antibodies demonstrated the specificity qualities required from such an antibody, antibody 3 had the best specificity qualities, and the lowest background signal. We thus recommend antibody 3 as the best option to detect endogenous *S. cerevisiae* Mdh2. This antibody can be used in western blot, as shown in this manuscript, and should be tested for other uses (e.g. ELISA, FACS, IP).

Data availability
=================

The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2018 Gabay-Maskit S et al.

Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication). <http://creativecommons.org/publicdomain/zero/1.0/>

**Dataset 1:** Raw images of all western blots included in figures presented. [10.5256/f1000research.13396.d212121](http://dx.doi.org/10.5256/f1000research.13396.d212121) ^[@ref-9]^
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As an antibody validation study the manuscript presented is complete, sufficient controls are included demonstrating the specificity of the antibodies for the Mdh2-protein with Ab3 sticking out as the best one because of low background. In figures 3 and 4 an unspecific band at the same size as the fusion proteins can be seen in many lanes, which is unfortunate raising doubts whether the Mdh2-mCherry or the GFP-Mdh2 are really specifically recognized. On the other hand, the native Mdh2-band at 41kD is missing in these lanes as expected increasing confidence into the specificity of the antibodies.

Since Mdh2p is the isoform involved in the glyoxylate cycle it can be expected that this protein will be well expressed under conditions requiring this metabolic pathway, e.g. on ethanol, acetate or oleate. From the data presented in this manuscript it is not possible to conclude that "the upregulation of Mdh2 in cells grown on oleic acid is due to removal of the glucose repression and not because of an oleic acid-specific up-regulation". For such a statement one would need to compare and present quantitative expression data from cells grown on non-repressing carbon sources such as ethanol and on oleate. It may well be that the expression of Mdh2 is derepressed on ethanol and further induced when grown on oleate. Since this is neither essential nor the primary subject of the antibody validation study I would suggest removing this sentence from the final version of the manuscript.
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